Literature DB >> 24790180

Soluble urokinase-type plasminogen activator receptor in FSGS: stirred but not shaken.

Jochen Reiser1, Harold Chapman2.   

Abstract

Keywords:  FSGS; podocyte; proteinuria

Mesh：

Substances：

Year:  2014        PMID： 24790180      PMCID： PMC4116074          DOI： 10.1681/ASN.2014030257

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  13 in total

1.  In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations.

Authors:  Pirouz Daftarian; Raquibul Chowdhury; Philip Ames; Changli Wei; Alan D King; Juan Pablo de Rivero Vaccari; Lloye Dillon; Justin Price; Howard Leung; Brittany Ashlock; Enrique Mesri; Victor Perez; Stephan Züchner; Jochen Reiser; Vance Lemmon; Robert W Keane
Journal:  Hybridoma (Larchmt)       Date:  2011-10

2.  Is there clinical value in measuring suPAR levels in FSGS?

Authors:  Sanja Sever; Howard Trachtman; Changli Wei; Jochen Reiser
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-25       Impact factor: 8.237

3.  Identification of the urokinase receptor as an adhesion receptor for vitronectin.

Authors:  Y Wei; D A Waltz; N Rao; R J Drummond; S Rosenberg; H A Chapman
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

4.  Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?

Authors:  Detlef Schlöndorff
Journal:  Kidney Int       Date:  2014-03       Impact factor: 10.612

5.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

6.  Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice.

Authors:  Dominique Cathelin; Sandrine Placier; Michael Ploug; Marie-Christine Verpont; Sophie Vandermeersch; Yosu Luque; Alexandre Hertig; Eric Rondeau; Laurent Mesnard
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121

7.  Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.

Authors:  Aditi Sinha; Jaya Bajpai; Savita Saini; Divya Bhatia; Aarti Gupta; Mamta Puraswani; Amit K Dinda; Sanjay K Agarwal; Shailaja Sopory; Ravindra M Pandey; Pankaj Hari; Arvind Bagga
Journal:  Kidney Int       Date:  2014-01-15       Impact factor: 10.612

8.  PAI1 stimulates assembly of the fibronectin matrix in osteosarcoma cells through crosstalk between the alphavbeta5 and alpha5beta1 integrins.

Authors:  Daniel Vial; Paula J McKeown-Longo
Journal:  J Cell Sci       Date:  2008-04-29       Impact factor: 5.285

9.  Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.

Authors:  V J Savin; R Sharma; M Sharma; E T McCarthy; S K Swan; E Ellis; H Lovell; B Warady; S Gunwar; A M Chonko; M Artero; F Vincenti
Journal:  N Engl J Med       Date:  1996-04-04       Impact factor: 91.245

10.  Circulating suPAR in two cohorts of primary FSGS.

Authors:  Changli Wei; Howard Trachtman; Jing Li; Chuanhui Dong; Aaron L Friedman; Jennifer J Gassman; June L McMahan; Milena Radeva; Karsten M Heil; Agnes Trautmann; Ali Anarat; Sevinc Emre; Gian M Ghiggeri; Fatih Ozaltin; Dieter Haffner; Debbie S Gipson; Frederick Kaskel; Dagmar-Christiane Fischer; Franz Schaefer; Jochen Reiser
Journal:  J Am Soc Nephrol       Date:  2012-11-08       Impact factor: 10.121
View more
  5 in total

1.  Ten-year advances in immunopathology of glomerulonephritis: translated into patients' care or lost in translation?

Authors:  Pierre Ronco; Jürgen Floege
Journal:  Semin Immunopathol       Date:  2014-07-24       Impact factor: 9.623

2.  suPAR is the circulating factor in some but not all FSGS.

Authors:  Howard Trachtman; Jochen Reiser
Journal:  Nat Rev Nephrol       Date:  2014-08-26       Impact factor: 28.314

3.  Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.

Authors:  Oliver Staeck; Torsten Slowinski; Ina Lieker; Kaiyin Wu; Birgit Rudolph; Danilo Schmidt; Susanne Brakemeier; Hans-Hellmut Neumayer; Changli Wei; Jochen Reiser; Klemens Budde; Fabian Halleck; Dmytro Khadzhynov
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

4.  Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method.

Authors:  Wolfgang Winnicki; Gere Sunder-Plassmann; Gürkan Sengölge; Ammon Handisurya; Harald Herkner; Christoph Kornauth; Bernhard Bielesz; Ludwig Wagner; Željko Kikić; Sahra Pajenda; Thomas Reiter; Benjamin Schairer; Alice Schmidt
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

Review 5.  Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association.

Authors:  Manuel Alfredo Podestà; Claudio Ponticelli
Journal:  Front Med (Lausanne)       Date:  2020-11-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.